Interchangeable Biosimilars Have Arrived In The U.S. - Life Sciences, Biotechnology & Nanotechnology
On July 28, 2021, the Food and Drug Administration (FDA) approved the first interchangeable biosimilar product...
Stay updated with breaking news from Reference Product. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On July 28, 2021, the Food and Drug Administration (FDA) approved the first interchangeable biosimilar product...
Nearly half (47%) of biosimilar users knew they were using biosimilars but 31% thought the medicine was an originator. In contrast, 80% of originator users knew they were using an originator, and none thought they were using a biosimilar.
Specialists define and discuss extrapolation, along with the importance of strong data in specific disease states.
Medical experts discuss interchangeability designation requirements for biosimilars.
Jonathan Kay, MD, and Kimberly C. Chen, DO, MSHLM, discuss clinical and financial concerns related to automatic substitution at the pharmacy for an interchangeable biosimilar from a payer perspective.